kneat.com, inc. (TSE:KSI – Free Report) – Research analysts at Cormark lifted their FY2026 earnings per share (EPS) estimates for kneat.com in a note issued to investors on Friday, October 11th. Cormark analyst G. Fairweather now expects that the company will post earnings per share of $0.05 for the year, up from their prior forecast of $0.04. The consensus estimate for kneat.com’s current full-year earnings is ($0.12) per share.
Separately, Ventum Cap Mkts upgraded kneat.com to a “strong-buy” rating in a report on Wednesday, August 7th.
kneat.com Trading Down 0.4 %
KSI opened at C$4.72 on Monday. The stock has a market cap of C$405.92 million, a PE ratio of -29.50, a price-to-earnings-growth ratio of 597.67 and a beta of 1.08. The company has a quick ratio of 1.50, a current ratio of 1.47 and a debt-to-equity ratio of 95.14. kneat.com has a twelve month low of C$2.68 and a twelve month high of C$5.17. The company has a fifty day moving average of C$4.74 and a 200-day moving average of C$4.35.
kneat.com (TSE:KSI – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported C($0.04) earnings per share (EPS) for the quarter, hitting the consensus estimate of C($0.04). kneat.com had a negative net margin of 31.19% and a negative return on equity of 51.13%. The firm had revenue of C$11.68 million during the quarter, compared to analyst estimates of C$11.45 million.
About kneat.com
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.
Recommended Stories
- Five stocks we like better than kneat.com
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- How to Capture the Benefits of Dividend Increases
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Best Stocks Under $10.00
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for kneat.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for kneat.com and related companies with MarketBeat.com's FREE daily email newsletter.